Wenshuang Wu

机构：Sichuan University, West China Hospital of Sichuan University, Dazhou Central Hospital · ORCID：0000-0002-1210-4865

发表论文 100 篇 · 总被引 2164 次 · h-index 27

代表论文

• Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition (2023 · Journal of Medicinal Chemistry · 被引 88)
• NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation (2024 · Science Advances · 被引 71)
• Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms (2023 · Drug Design Development and Therapy · 被引 49)
• Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury (2023 · Journal of Medicinal Chemistry · 被引 21)
• Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis (2023 · Journal of Medicinal Chemistry · 被引 18)
• Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization (2024 · Journal of Medicinal Chemistry · 被引 17)